On April 8, a strategic session of the Association of Russian Pharmaceutical Manufacturers, uniting the leaders of the local pharmaceutical industry, took place. During the session, the main goals and objectives of the Association for the near future were identified, among which: activities to improve the pricing system for medicines, adjusting regulations aimed at providing […]


On April 1, 2021, Sun Pharmaceutical Industries Limited (India), another company that localized production in the Russian Federation, joined ARPM. Sun Pharma is focused on the Russian market and deep localization of production. PJSC «Biosintez» is the company’s production site in the Penza region, and today it produces more than 180 drugs, 70% of which […]

маркировка лек

Recall that the Association of Russian Pharmaceutical Manufacturers as early as February 1, 2021, turned to the Ministry of Industry and Trade following the results of a round table held on January 27 at the RF CCI with a proposal to amend the standard form of an agreement for the provision of labeling services to […]


For two days, the platforms of Komsomolskaya Pravda and the Eurasian Pharmaceutical Forum became centers for discussion of the most acute and relevant topic today — drug labeling. The participants of the discussion raised issues related to technical nuances, adjusting the system during the transition period, correcting errors and interacting with the DMM (Drug Movement […]


JSC «Valenta Pharm», which stood at the origins of the foundation of the Association of Russian Pharmaceutical Manufacturers (ARPM), is renewing its membership in the Association since 2021. Since 2002, when ARPM was founded, there have been many changes in the Russian pharmaceutical market — the market itself has grown significantly, new Russian enterprises have […]


The Interfactional Working Group on Improving the Legislation in the Sphere of Medicinal Provision of Citizens and the Circulation of Medicines of the State Duma supported the proposals of the participants of the meeting, which took place online, on the need to amend by-laws regulating the functioning of the DMM system. In particular, they talked […]


This exact aphorism of the moderator of the panel session, Alexei Kuzmin, became the leitmotif of the entire conference “Mandatory Labeling of Medicinal Products: Preparation and Implementation”, which took place on 26 January in an online format. Participants of all links in the distribution chain of various product groups shared their experience, told colleagues who […]


Failures in the labeling system lead to a shortage of drugs on the market. Hundreds of millions of packages of medicines have accumulated in warehouses and quarantine zones of the distribution chain. To avoid a collapse, the Government has simplified the procedure for working with the drug monitoring system. The new regime will operate until […]


The XII scientific-practical conference "State regulation and the Russian pharmaceutical industry: continuation of the dialogue", organized by the Association of Russian pharmaceutical manufacturers and the National Research Institute of Public Health named after N.A. Semashko. The event was attended by representatives of regulatory authorities, expert organizations, pharmaceutical companies, medical communities and patient organizations. The discussion […]


2020 was the year of bringing the drug dossier in correspondence with the unified rules of the EAEU, but the COVID-19 pandemic intervened in this process. In the union states, GMP inspection of sites has been temporarily suspended, and in Russia remote methods of checking good manufacturing practices are being introduced. These are not the […]